Τετάρτη 15 Απριλίου 2020

Cancer Medicine

Association between cancer‐specific adverse event triggers and mortality: A validation study
In a retrospective longitudinal cohort of 322 887 newly diagnosed patients with breast, colorectal, lung, or prostate cancer, there was increased one‐year mortality among patients who experienced oncology‐specific claims‐based triggers compared to patients without triggers. Increased mortality was observed across all cancer types, stratified by metastatic status, in unadjusted and multivariate analyses. Abstract Background As there are few validated measures of patient safety in clinical oncology,...
Cancer Medicine
22h
Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
Overall survival with pancreatic ductal adenocarcinoma is influenced by where treatment is received, for all races/ethnicities. While racial/ethnic disparities affect overall survival, further subclassification of Hispanics into regions of origin has significant implications in survival and clinical outcomes with pancreatic ductal adenocarcinoma. Abstract Background Disparities exist among patients with pancreatic ductal adenocarcinoma (PDAC). Non‐White race is regarded as a negative predictor...
Cancer Medicine
22h

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου